Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06446570
Status:
COMPLETED
Last Update Posted:
2024-06-06
First Post:
2024-05-31
Brief Title:
Phase II Study of DurvalumabMEDI4736 Tremelimumab in Pulmonary Sarcomatoid Carcinoma
Sponsor:
Organization:
Seoul National University Hospital